68Ga-JH12 PET/CT: Dosimetry and Biodistribution Study

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions

Malignant Neoplasm

Interventions

DRUG

68Ga-JH12

The dose will be 148-222 MBq given intravenously.

Trial Locations (1)

RECRUITING

Department of Nuclear Medicine, First Affiliated Hospital of Fujian Medical University, Fuzhou

All Listed Sponsors

lead

First Affiliated Hospital of Fujian Medical University

OTHER